PD-1 and PD-L1 Up-regulation Promotes T-cell Apoptosis in Gastric Adenocarcinoma

Area of Science:

• Immunology
• Oncology
• Gastroenterology

Background:

• The programmed death 1 (PD-1) receptor and its ligand (PD-L1) are crucial regulators of immune responses.
• The inhibitory impact of the PD-1/PD-L1 pathway on tumor-infiltrating T lymphocytes in gastric adenocarcinoma remains unclear.

Purpose of the Study:

• To investigate the expression of PD-1 and PD-L1 in gastric adenocarcinoma patients.
• To analyze the correlation between PD-1/PD-L1 expression and disease progression.
• To explore the functional role of PD-1/PD-L1 in T cell-mediated immunity within the tumor microenvironment.

Main Methods:

• Characterized PD-1 and PD-L1 expression in peripheral blood and tumor-infiltrating cells from 60 patients (gastric adenocarcinoma, gastritis, asymptomatic controls).
• Analyzed the association between PD-1/PD-L1 expression and disease progression.
• Conducted in vitro experiments to assess T cell-PD-L1 interactions and the effect of PD-L1 blockade.

Main Results:

• PD-1 expression on T cells (both peripheral and tumor-infiltrating) was elevated with increasing disease severity.
• In vitro studies demonstrated that T cells induced PD-L1 on gastric adenocarcinoma cells via IFN-γ.
• This interaction led to T cell apoptosis, which was reversed by blocking PD-L1.

Conclusions:

• The PD-1/PD-L1 pathway plays a significant role in immune evasion in gastric adenocarcinoma.
• PD-L1 represents a promising therapeutic target for gastric adenocarcinoma treatment.